StockUS listing USITGRNYSEHealthcareProfitless Growth

Integer Holdings Corp(ITGR) Stock Analysis | Healthcare

USD --+0.00%
Reward53Moderate
Risk43Moderate
75%Data
USD —+0.00 (+0.00%) Previous close · NYSE
Market cap 4.30Bn
Reward Ratingⓘ53 Moderate reward assessment · 75% data coverage
Bottom 50% of stocksView factors
Risk Ratingⓘ43 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on ITGR to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Integer Holdings Corp?

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.

AI Brief Pro

The brief on Integer Holdings Corp

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Integer Holdings Corp?

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 4.30B, and a P/E ratio of 34.6x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (53)

Similar stocks to compare

A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryMedical Devices
P/E Ratio34.6438
Beta0.615
Insider Activity
12M windowBullish
Shares soldShares bought
0-3months
0
0
3-6months
0
0
6-9months
1825 shares
$70k
0
9-12months
1884 shares
$62k
35,843 shares
$385k